dba fitc conjugated Search Results


94
Vector Laboratories fluorescein labeled dolichos biflorus agglutinin (dba)
Fluorescein Labeled Dolichos Biflorus Agglutinin (Dba), supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba+fitc+conjugated/custom%40fl-1031%4040992739?v=Vector+Laboratories
Average 94 stars, based on 1 article reviews
fluorescein labeled dolichos biflorus agglutinin (dba) - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier

90
EY Laboratories fitc-conjugated anti-dolichos biflorus lectin (dba) antibody
Fitc Conjugated Anti Dolichos Biflorus Lectin (Dba) Antibody, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba+fitc+conjugated/pm12761253-91-0-9?v=EY+Laboratories
Average 90 stars, based on 1 article reviews
fitc-conjugated anti-dolichos biflorus lectin (dba) antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
US Biological Life Sciences fitc-conjugated dolichos biflorus agglutinin (dba) lectin
(A) Schematic showing experimental strategy used to selectively inhibit Cox2. Celecoxib was administered by oral gavage on E6.5 after implantation but before peak decidualization (E7.5). ( B) Representative Western blot of Cox2, IL-15, and actin in C57 E7.5 and BPH/5 E7.5 implantation sites. (C) Quantification of Cox2 protein and (D) IL-15 protein levels relative to actin in C57 and BPH/5 E7.5 implantation sites after vehicle or celecoxib administration. n = 3 for the vehicle-treated group; n = 4 for the celecoxib-treated group. * P < 0.05 versus vehicle-treated C57 mice and † P < 0.05 versus vehicle-treated BPH/5 mice, by 1-way ANOVA. (E) Representative dot plot of <t>DBA</t> +CD122+-stained cells from BPH/5 E7.5 implantation sites as measured by flow cytometry. Numbers in the boxes reflect the percentage of the total cells recovered that were found to be <t>CD122+DBA-lectin+.</t> (F) Quantitative summary of flow cytometry of DBA +CD122+-stained cells from BPH/5 E7.5 implantation sites for vehicle- ( n = 5) versus celecoxib-treated mice. n = 7. † P < 0.05 versus vehicle-treated BPH/5 mice, by 2-tailed Student’s t test. Data represent the mean ± SEM. dNK, decidual NK; Dpc, days postcoitus; veh, vehicle.
Fitc Conjugated Dolichos Biflorus Agglutinin (Dba) Lectin, supplied by US Biological Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba+fitc+conjugated/pmc04855694-438-0-6?v=US+Biological+Life+Sciences
Average 90 stars, based on 1 article reviews
fitc-conjugated dolichos biflorus agglutinin (dba) lectin - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
EY Laboratories bile duct-specific lectin, dolichos biflorus agglutinin (dba) conjugated with fitc
(A) Schematic showing experimental strategy used to selectively inhibit Cox2. Celecoxib was administered by oral gavage on E6.5 after implantation but before peak decidualization (E7.5). ( B) Representative Western blot of Cox2, IL-15, and actin in C57 E7.5 and BPH/5 E7.5 implantation sites. (C) Quantification of Cox2 protein and (D) IL-15 protein levels relative to actin in C57 and BPH/5 E7.5 implantation sites after vehicle or celecoxib administration. n = 3 for the vehicle-treated group; n = 4 for the celecoxib-treated group. * P < 0.05 versus vehicle-treated C57 mice and † P < 0.05 versus vehicle-treated BPH/5 mice, by 1-way ANOVA. (E) Representative dot plot of <t>DBA</t> +CD122+-stained cells from BPH/5 E7.5 implantation sites as measured by flow cytometry. Numbers in the boxes reflect the percentage of the total cells recovered that were found to be <t>CD122+DBA-lectin+.</t> (F) Quantitative summary of flow cytometry of DBA +CD122+-stained cells from BPH/5 E7.5 implantation sites for vehicle- ( n = 5) versus celecoxib-treated mice. n = 7. † P < 0.05 versus vehicle-treated BPH/5 mice, by 2-tailed Student’s t test. Data represent the mean ± SEM. dNK, decidual NK; Dpc, days postcoitus; veh, vehicle.
Bile Duct Specific Lectin, Dolichos Biflorus Agglutinin (Dba) Conjugated With Fitc, supplied by EY Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dba+fitc+conjugated/pm18004941-52-21-27?v=EY+Laboratories
Average 90 stars, based on 1 article reviews
bile duct-specific lectin, dolichos biflorus agglutinin (dba) conjugated with fitc - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic showing experimental strategy used to selectively inhibit Cox2. Celecoxib was administered by oral gavage on E6.5 after implantation but before peak decidualization (E7.5). ( B) Representative Western blot of Cox2, IL-15, and actin in C57 E7.5 and BPH/5 E7.5 implantation sites. (C) Quantification of Cox2 protein and (D) IL-15 protein levels relative to actin in C57 and BPH/5 E7.5 implantation sites after vehicle or celecoxib administration. n = 3 for the vehicle-treated group; n = 4 for the celecoxib-treated group. * P < 0.05 versus vehicle-treated C57 mice and † P < 0.05 versus vehicle-treated BPH/5 mice, by 1-way ANOVA. (E) Representative dot plot of DBA +CD122+-stained cells from BPH/5 E7.5 implantation sites as measured by flow cytometry. Numbers in the boxes reflect the percentage of the total cells recovered that were found to be CD122+DBA-lectin+. (F) Quantitative summary of flow cytometry of DBA +CD122+-stained cells from BPH/5 E7.5 implantation sites for vehicle- ( n = 5) versus celecoxib-treated mice. n = 7. † P < 0.05 versus vehicle-treated BPH/5 mice, by 2-tailed Student’s t test. Data represent the mean ± SEM. dNK, decidual NK; Dpc, days postcoitus; veh, vehicle.

Journal: JCI insight

Article Title: Decidual Cox2 inhibition improves fetal and maternal outcomes in a preeclampsia-like mouse model

doi: 10.1172/jci.insight.75351

Figure Lengend Snippet: (A) Schematic showing experimental strategy used to selectively inhibit Cox2. Celecoxib was administered by oral gavage on E6.5 after implantation but before peak decidualization (E7.5). ( B) Representative Western blot of Cox2, IL-15, and actin in C57 E7.5 and BPH/5 E7.5 implantation sites. (C) Quantification of Cox2 protein and (D) IL-15 protein levels relative to actin in C57 and BPH/5 E7.5 implantation sites after vehicle or celecoxib administration. n = 3 for the vehicle-treated group; n = 4 for the celecoxib-treated group. * P < 0.05 versus vehicle-treated C57 mice and † P < 0.05 versus vehicle-treated BPH/5 mice, by 1-way ANOVA. (E) Representative dot plot of DBA +CD122+-stained cells from BPH/5 E7.5 implantation sites as measured by flow cytometry. Numbers in the boxes reflect the percentage of the total cells recovered that were found to be CD122+DBA-lectin+. (F) Quantitative summary of flow cytometry of DBA +CD122+-stained cells from BPH/5 E7.5 implantation sites for vehicle- ( n = 5) versus celecoxib-treated mice. n = 7. † P < 0.05 versus vehicle-treated BPH/5 mice, by 2-tailed Student’s t test. Data represent the mean ± SEM. dNK, decidual NK; Dpc, days postcoitus; veh, vehicle.

Article Snippet: FITC-conjugated Dolichos biflorus agglutinin (DBA) lectin (US Biological) was also used as a cell-surface marker.

Techniques: Western Blot, Staining, Flow Cytometry